BRPI0817830A2 - Composições imunogênicas contendo flagelos h7 de eschericha coli e métodos de uso das mesmas - Google Patents

Composições imunogênicas contendo flagelos h7 de eschericha coli e métodos de uso das mesmas

Info

Publication number: BRPI0817830A2
Authority: BR; Brazil
Prior art keywords: methods; compositions containing; immunogenic compositions; eschericha coli; flagella
Prior art date: 2007-10-17

Application number

Other languages

English (en)

Inventor

David Gally

Tom Nathan Mcneilley

David George Emslie Smith

Chris Low

Arvind Kumar Mahajan

Stuart W Naylor

Original Assignee

Univ Edinburgh

Scottish Agricultural College

Moredun Res Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-17

Filing date

2008-10-17

Publication date

2015-04-07

2008-10-17 Application filed by Univ Edinburgh, Scottish Agricultural College, Moredun Res Inst filed Critical Univ Edinburgh

2015-04-07 Publication of BRPI0817830A2 publication Critical patent/BRPI0817830A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

BRPI0817830 2007-10-17 2008-10-17 Composições imunogênicas contendo flagelos h7 de eschericha coli e métodos de uso das mesmas BRPI0817830A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0720250.0A GB0720250D0 (en)	2007-10-17	2007-10-17	Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
PCT/GB2008/003515 WO2009050474A1 (en)	2007-10-17	2008-10-17	Immunogenic ompositions containing escherichia coli h7 flagella and methods of use thereof

Publications (1)

Publication Number	Publication Date
BRPI0817830A2 true BRPI0817830A2 (pt)	2015-04-07

Family

ID=38813935

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0817830 BRPI0817830A2 (pt)	2007-10-17	2008-10-17	Composições imunogênicas contendo flagelos h7 de eschericha coli e métodos de uso das mesmas

Country Status (6)

Country	Link
US (2)	US9193770B2 (pt)
EP (2)	EP2626370B1 (pt)
BR (1)	BRPI0817830A2 (pt)
CA (1)	CA2702856C (pt)
GB (1)	GB0720250D0 (pt)
WO (1)	WO2009050474A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0720250D0 (en) *	2007-10-17	2007-11-28	Univ Edinburgh	Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
CL2014001126A1 (es) *	2014-04-29	2014-08-29	Univ Chile	Composición farmacéutica útil como vacuna contra bacterias escherichia coli productoras de shigatoxinas (stec), que comprende al menos un antígeno o una proteína de membrana externa inmunogénica o proteína inmunogénica asociada y conservada en cepas stec.
US10676723B2 (en)	2015-05-11	2020-06-09	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
CN108977413B (zh) *	2017-06-05	2021-02-23	华中农业大学	一种表达双拷贝gD基因的重组牛传染性鼻气管炎病毒
CN113981148A (zh) *	2021-11-18	2022-01-28	中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心）	一种鉴别rv感染以及鉴定病毒基因型的方法及其应用
WO2025040870A1 (en)	2023-08-23	2025-02-27	Epitogenx Limited	Bio-engineered flagellin-derived scaffold backbone and uses thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4342566A (en)	1980-02-22	1982-08-03	Scripps Clinic & Research Foundation	Solid phase anti-C3 assay for detection of immune complexes
GB8308235D0 (en)	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en)	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
CA1319101C (en)	1986-09-03	1993-06-15	Marta Iris Sabara	Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules
US6673776B1 (en)	1989-03-21	2004-01-06	Vical Incorporated	Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
ZA918426B (en)	1990-10-31	1992-12-30	Akzo Nv	Chicken anemia virus vaccine and diagnostic
EP0486106A3 (en)	1990-11-16	1992-12-23	Akzo N.V.	Marek's disease virus vaccine
US6034298A (en)	1991-08-26	2000-03-07	Prodigene, Inc.	Vaccines expressed in plants
US5612487A (en)	1991-08-26	1997-03-18	Edible Vaccines, Inc.	Anti-viral vaccines expressed in plants
US5712118A (en)	1993-09-29	1998-01-27	Research Foundation Of State University Of New York	Vaccine for branhamella catarrhalis
US6150170A (en)	1998-05-03	2000-11-21	University Of Maryland At Baltimore	Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US6682729B1 (en)	1995-05-03	2004-01-27	University Of Maryland, Baltimore	Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5877159A (en)	1995-05-03	1999-03-02	University Of Maryland At Baltimore	Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US5824538A (en)	1995-09-06	1998-10-20	The United States Of America As Represented By The Secretary Of The Army	Shigella vector for delivering DNA to a mammalian cell
CA2305785A1 (en)	1997-10-07	1999-04-15	University Of Maryland Biotechnology Institute	Method for introducing and expressing rna in animal cells
AUPP363498A0 (en) *	1998-05-21	1998-06-11	University Of Sydney, The	Antigens and their detection
WO2001023537A1 (en)	1999-09-24	2001-04-05	Cyto Pulse Sciences, Inc.	Process for enhancing electric field-mediated delivery of biological materials into cells
AU2001240109A1 (en)	2000-03-07	2001-09-17	U.S. Army Medical Research Institute Of Infectious Diseases	Dna vaccines against poxviruses
WO2001068889A2 (en)	2000-03-16	2001-09-20	Malone Robert W	Method for gene transfection and vaccination through skin using electropermeabilization
EP1678316B1 (en) *	2003-09-19	2011-08-17	Epitopix, LLC	Campylobacter polypeptides and methods of use
US20070128183A1 (en) *	2004-04-27	2007-06-07	Intercell Ag	Td antigens
SG160424A1 (en) *	2004-12-21	2010-04-29	Vaxinnate Corp	Compositions of influenza viral proteins and methods of use thereof
US7374055B2 (en) *	2004-12-22	2008-05-20	Graham Packaging Company, L.P.	Container having controlled top load characteristics
US20070224205A1 (en) *	2006-03-07	2007-09-27	Powell Thomas J	Compositions that include hemagglutinin, methods of making and methods of use thereof
WO2008097016A1 (en) *	2007-02-09	2008-08-14	Chonnam National University	Modified flagellin improved toll-like receptor 5 stimulating activity
WO2009033009A2 (en) *	2007-09-05	2009-03-12	Inotek Pharmaceuticals Corporation	Antibodies against flagellin and uses thereof
GB0720250D0 (en) *	2007-10-17	2007-11-28	Univ Edinburgh	Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
SG190562A1 (en) *	2008-04-18	2013-06-28	Vaxinnate Corp	Deletion mutants of flagellin and methods of use
US8647642B2 (en) *	2008-09-18	2014-02-11	Aviex Technologies, Llc	Live bacterial vaccines resistant to carbon dioxide (CO2), acidic PH and/or osmolarity for viral infection prophylaxis or treatment
US8486408B2 (en) *	2008-10-03	2013-07-16	Emory University	Methods for the treatment of graft-versus-host disease
US20100239583A1 (en) *	2009-03-04	2010-09-23	Inotek Pharmaceuticals Corporation	Antibodies against flagellin and uses thereof
ES1072604Y (es) *	2010-06-04	2010-10-29	Pelaez Antonio Fernandez	Dispositivo de desatasco de una tolva
CN103037887B (zh) *	2010-06-25	2017-11-10	国家医疗保健研究所	用于治疗呼吸道感染的方法和药物组合物
CN104884959B (zh) *	2012-10-05	2017-12-01	雀巢产品技术援助有限公司	作为ibs的诊断标志物的微生物组抗体、应激因子和肥大细胞标志物
US9919029B2 (en) *	2013-07-26	2018-03-20	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of bacterial infections
JP2018502086A (ja) *	2014-12-24	2018-01-25	アンスティチュナショナルドゥラサンテエドゥラルシェルシュメディカル	慢性閉塞性肺疾患の急性増悪の処置のための方法及び医薬組成物

2007
- 2007-10-17 GB GBGB0720250.0A patent/GB0720250D0/en not_active Ceased
2008
- 2008-10-17 EP EP12186872.3A patent/EP2626370B1/en active Active
- 2008-10-17 BR BRPI0817830 patent/BRPI0817830A2/pt not_active Application Discontinuation
- 2008-10-17 US US12/738,627 patent/US9193770B2/en not_active Expired - Fee Related
- 2008-10-17 WO PCT/GB2008/003515 patent/WO2009050474A1/en not_active Ceased
- 2008-10-17 EP EP08838826.9A patent/EP2201029B1/en not_active Not-in-force
- 2008-10-17 CA CA2702856A patent/CA2702856C/en not_active Expired - Fee Related
2015
- 2015-11-23 US US14/949,291 patent/US10363297B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2009050474A1 (en)	2009-04-23
EP2626370A1 (en)	2013-08-14
EP2626370B1 (en)	2021-06-23
EP2201029A1 (en)	2010-06-30
US9193770B2 (en)	2015-11-24
CA2702856A1 (en)	2009-04-23
EP2201029B1 (en)	2017-01-18
US20110008379A1 (en)	2011-01-13
GB0720250D0 (en)	2007-11-28
US20160074493A1 (en)	2016-03-17
CA2702856C (en)	2017-12-05
US10363297B2 (en)	2019-07-30

Publication	Publication Date	Title
BRPI0822104A2 (pt)	2014-10-07	Composições antimicrobianas e métodos para o uso das mesmas
BRPI0813627A2 (pt)	2014-12-23	Peptídio antimicrobiano, composições e métodos de uso
BRPI0910852A2 (pt)	2018-05-29	composições contendo lipídios e métodos de uso das mesmas
BRPI0911297A2 (pt)	2019-09-24	composição e métodos para preparo e uso das mesmas
BRPI0911688A2 (pt)	2015-07-28	"compostos de pirimidina, composições e métodos de uso"
SMT201400181B (it)	2015-01-15	Composizioni per vasocostrizione e metodi d'uso
BRPI0819299A2 (pt)	2014-10-07	Uso de composição, e, composição contendo proteína
BRPI0810524A2 (pt)	2014-10-21	Derivado de (aza)indol e uso do mesmo para propósitos médicos
BRPI0914488A2 (pt)	2015-10-27	"composições de limpeza incluindo siloxanos de sorbitano modificados e uso das mesmas"
BRPI0912703A2 (pt)	2017-06-13	composições imuno-moduladoras e métodos para uso dessas
BRPI0912717A2 (pt)	2014-12-23	Composição farmacêutica, e, uso de 5-azacitidina
BRPI0809926A2 (pt)	2014-10-07	Composições imunogênicas compreendendo polipeptídios de mycobacterium tuberculosis e fusões dos mesmos
BRPI0915928A2 (pt)	2015-11-03	composições e métodos de uso para anticorpos terapêuticos
IL190885A0 (en)	2008-11-03	Immunogenic compositions and methods of use
BRPI0913086A2 (pt)	2015-08-04	Composições antimicrobianas e métodos de uso
BRPI1005670A2 (pt)	2017-03-28	composições adjuvantes e métodos de uso
SMT201500213B (it)	2015-10-30	Alcune triazolopirazine, loro composizioni e metodi d'uso
BRPI0814594A2 (pt)	2015-01-20	Composições e métodos adjuvantes de antígeno
BRPI0809346A2 (pt)	2014-10-07	Compostos derivados substituídos de imidazopiridina e composição farmacêutica contendo os mesmos
BRPI0720124A2 (pt)	2014-03-04	Composições farmacêuticas e seus métodos de uso.
BRPI0818003A2 (pt)	2019-09-24	inibidores de csf-1r, composições e métodos de uso
DK1982964T3 (da)	2019-05-20	Blanding indeholdende organosiliciumforbindelse og anvendelse heraf
BRPI1011876A2 (pt)	2015-09-22	"composição farmacêutica estável e métodos de uso da mesma"
BRPI0909954A2 (pt)	2015-11-03	"diazacarbazóis e métodos de uso"
BRPI0820899A2 (pt)	2014-09-30	Formulação cosmética, e, uso da composição

Legal Events

Date	Code	Title	Description
2016-12-06	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2017-07-04	B09B	Patent application refused [chapter 9.2 patent gazette]
2018-05-29	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL